IDEXX Laboratories Investor Presentation 2023 | Raymond James Conference

IDEXX Laboratories presented at the Raymond James 44th Annual Institutional Investors Conference on March 6, 2023, outlining its strategy to increase companion animal healthcare globally through innovative diagnostic and software solutions. The company highlighted a $37 billion total addressable market and projected long-term organic growth potential of 10%+ with high return on invested capital. IDEXX's integrated offerings target improved diagnostic utilization and expanded international commercial presence in the pet healthcare sector.